Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) Stock: Insider Albert Cha Acquires 300,000 Shares

by · The Markets Daily

Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC – Get Free Report) CEO Albert Cha bought 300,000 shares of Frazier Life Sciences Acquisition Corp. II stock in a transaction dated Thursday, October 15th. The stock was acquired at an average cost of $10.00 per share, with a total value of $3,000,000.00. Following the transaction, the chief executive officer owned 300,000 shares of the company’s stock, valued at $3,000,000. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Frazier Life Sciences Acquisition Corp. II Stock Performance

Shares of FLSC stock traded up $0.20 on Thursday, hitting $10.49. The company’s stock had a trading volume of 84,224 shares. Frazier Life Sciences Acquisition Corp. II has a fifty-two week low of $10.18 and a fifty-two week high of $10.50.

About Frazier Life Sciences Acquisition Corp. II

(Get Free Report)

Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company, or SPAC, focused on identifying and combining with a business in the life sciences sector. The company does not operate a conventional commercial business and was formed to pursue a merger, acquisition, or similar business combination.

Its target opportunities may include companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, or other healthcare-related technologies. The company’s objective is to provide a publicly traded platform for a private life sciences business through a business combination.

Frazier Life Sciences Acquisition Corp.

Recommended Stories